105 related articles for article (PubMed ID: 15791435)
1. Pharmacokinetics and biodistribution of 177Lu-labeled multivalent single-chain Fv construct of the pancarcinoma monoclonal antibody CC49.
Chauhan SC; Jain M; Moore ED; Wittel UA; Li J; Gwilt PR; Colcher D; Batra SK
Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):264-73. PubMed ID: 15791435
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and biodistribution of a light-chain-shuffled CC49 single-chain Fv antibody construct.
Pavlinkova G; Colcher D; Booth BJ; Goel A; Batra SK
Cancer Immunol Immunother; 2000 Jul; 49(4-5):267-75. PubMed ID: 10941910
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and biodistribution of radioimmunoconjugates of anti-CD19 antibody and single-chain Fv for treatment of human B-cell malignancy.
Li Q; Hudson W; Wang D; Berven E; Uckun FM; Kersey JH
Cancer Immunol Immunother; 1998 Nov; 47(3):121-30. PubMed ID: 9829837
[TBL] [Abstract][Full Text] [Related]
4. Rhenium-186-mercaptoacetyltriglycine-labeled monoclonal antibody for radioimmunotherapy: in vitro assessment, in vivo kinetics and dosimetry in tumor-bearing nude mice.
Kinuya S; Yokoyama K; Tega H; Hiramatsu T; Konishi S; Yamamoto W; Shuke N; Aburano T; Watanabe N; Takayama T; Michigishi T; Tonami N
Jpn J Cancer Res; 1998 Aug; 89(8):870-8. PubMed ID: 9765625
[TBL] [Abstract][Full Text] [Related]
5. The Thomsen-Friedenreich disaccharide as antigen for in vivo tumor targeting with multivalent scFvs.
Ravn P; Stahn R; Danielczyk A; Faulstich D; Karsten U; Goletz S
Cancer Immunol Immunother; 2007 Sep; 56(9):1345-57. PubMed ID: 17310382
[TBL] [Abstract][Full Text] [Related]
6. 166Ho and 90Y labeled 6D2 monoclonal antibody for targeted radiotherapy of melanoma: comparison with 188Re radiolabel.
Thompson S; Ballard B; Jiang Z; Revskaya E; Sisay N; Miller WH; Cutler CS; Dadachova E; Francesconi LC
Nucl Med Biol; 2014 Mar; 41(3):276-81. PubMed ID: 24533987
[TBL] [Abstract][Full Text] [Related]
7. Improved targeting of an anti-TAG-72 antibody drug conjugate for the treatment of ovarian cancer.
Minnix M; Li L; Yazaki P; Chea J; Poku E; Colcher D; Shively JE
Cancer Med; 2020 Jul; 9(13):4756-4767. PubMed ID: 32368864
[TBL] [Abstract][Full Text] [Related]
8. Antibody-dependent difference in biodistribution of monoclonal antibodies in animal models and humans.
Oriuchi N; Watanabe N; Kanda H; Hashimoto M; Sugiyama S; Takenoshita S; Imai K; Ueda R; Endo K
Cancer Immunol Immunother; 1998 Aug; 46(6):311-7. PubMed ID: 9756415
[TBL] [Abstract][Full Text] [Related]
9. Production and validation of the pharmacokinetics of a single-chain Fv fragment of the MGR6 antibody for targeting of tumors expressing HER-2.
Turatti F; Mezzanzanica D; Nardini E; Luison E; Maffioli L; Bambardieri E; de Lalla C; Canevari S; Figini M
Cancer Immunol Immunother; 2001 Feb; 49(12):679-86. PubMed ID: 11258794
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer Exhibits Antitumor Efficacy with Low Toxicity.
Tully KM; Tendler S; Carter LM; Sharma SK; Samuels ZV; Mandleywala K; Korsen JA; Delos Reyes AM; Piersigilli A; Travis WD; Sen T; Pillarsetty N; Poirier JT; Rudin CM; Lewis JS
Clin Cancer Res; 2022 Apr; 28(7):1391-1401. PubMed ID: 35046060
[TBL] [Abstract][Full Text] [Related]
11. Optimization of in vivo tumor targeting in SCID mice with divalent forms of 741F8 anti-c-erbB-2 single-chain Fv: effects of dose escalation and repeated i.v. administration.
Adams GP; McCartney JE; Wolf EJ; Eisenberg J; Tai MS; Huston JS; Stafford WF; Bookman MA; Houston LL; Weiner LM
Cancer Immunol Immunother; 1995 May; 40(5):299-306. PubMed ID: 7600561
[TBL] [Abstract][Full Text] [Related]
12. Predictors of long-term outcome from intraperitoneal radioimmunotherapy for ovarian cancer.
Meredith R; You Z; Alvarez R; Partridge E; Grizzle W; LoBuglio A
Cancer Biother Radiopharm; 2012 Feb; 27(1):36-40. PubMed ID: 22239432
[TBL] [Abstract][Full Text] [Related]
13. Preclinical optimization of antibody-based radiopharmaceuticals for cancer imaging and radionuclide therapy-Model, vector, and radionuclide selection.
Carter LM; Poty S; Sharma SK; Lewis JS
J Labelled Comp Radiopharm; 2018 Jul; 61(9):611-635. PubMed ID: 29412489
[TBL] [Abstract][Full Text] [Related]
14. Postural effects on peritoneal transport and systemic uptake of radiolabeled monoclonal antibodies.
Barrett JS; Fisher SJ; Wahl RL
Cancer Immunol Immunother; 1997 May; 44(3):173-8. PubMed ID: 9191877
[TBL] [Abstract][Full Text] [Related]
15. Aligning physics and physiology: Engineering antibodies for radionuclide delivery.
Tsai WK; Wu AM
J Labelled Comp Radiopharm; 2018 Jul; 61(9):693-714. PubMed ID: 29537104
[TBL] [Abstract][Full Text] [Related]
16. Antibody engineering to generate anti-tumor-associated glycoprotein 72 mouse recombinant CC49 IgG with improved solubility, purity, and thermal stability.
Lin Z; Tu B; Hemken PM; Muerhoff AS
J Immunol Methods; 2024 Feb; 525():113606. PubMed ID: 38145790
[TBL] [Abstract][Full Text] [Related]
17. Intravital Microscopy Reveals Unforeseen Biodistribution Within the Liver and Kidney Mechanistically Connected to the Clearance of a Bifunctional Antibody.
Datta-Mannan A; Molitoris BA; Feng Y; Martinez MM; Sandoval RM; Brown RM; Merkel D; Croy JE; Dunn KW
Drug Metab Dispos; 2023 Mar; 51(3):403-412. PubMed ID: 36460476
[TBL] [Abstract][Full Text] [Related]
18. Conjugation of Antibodies with Radiogold Nanoparticles, as an Effector Targeting Agents in Radiobioconjugate Cancer Therapy: Optimized Labeling and Biodistribution Results.
Garg P; Hazra DK
Indian J Nucl Med; 2017; 32(4):296-303. PubMed ID: 29142346
[TBL] [Abstract][Full Text] [Related]
19. Electrostatic properties of human germlines and biodistribution of small biologics.
De Souza Cordeiro LM; Atkinson KC; Aivazian A; Joyce PF; Jia F; Mascioni A
MAbs; 2024; 16(1):2311991. PubMed ID: 38334129
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of site-specific Fab-drug conjugates using ADP-ribosyl cyclases.
Kim HS; Hariri K; Zhang XN; Chen LC; Katz BB; Pei H; Louie SG; Zhang Y
Protein Sci; 2024 Apr; 33(4):e4924. PubMed ID: 38501590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
